For Urinary Incontinence, Try Behavioral Treatments or Drugs, or Both
Bladder training, biofeedback and other behavioral therapies may work even better in combination with drugs. (Source: NYT Health)
Source: NYT Health - March 22, 2019 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Incontinence Biofeedback Drugs (Pharmaceuticals) Acupuncture Source Type: news

One in 20 women injured in the vaginal mesh scandal have attempted suicide
A survey of more than 650 women in the UK who had the controversial implant to treat their prolapse or urinary incontinence also revealed one in 20 are in such severe pain they regularly self-harm. (Source: the Mail online | Health)
Source: the Mail online | Health - March 19, 2019 Category: Consumer Health News Source Type: news

Behavioral Therapy as Good as Meds for Incontinence Behavioral Therapy as Good as Meds for Incontinence
A network meta-analysis suggests behavioral therapy may be as good as medication for treating urinary incontinence in women; the results confirm international guidelines.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 19, 2019 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

One in three women suffers with incontinence, so we rate a range of products that claim to help...
We asked Dr Penelope Law, a consultant obstetrician and gynaecologist at Hillingdon Hospital and The Portland Hospital in London, to assess a selection. We then rated them. (Source: the Mail online | Health)
Source: the Mail online | Health - March 18, 2019 Category: Consumer Health News Source Type: news

Active Interventions Generally Helpful for Urinary Incontinence
MONDAY, March 18, 2019 -- Most active interventions are more likely than no treatment to improve outcomes for women with either stress or urgency urinary incontinence (UI), according to a review published online March 19 in the Annals of Internal... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 18, 2019 Category: Pharmaceuticals Source Type: news

RDD Pharma Appoints John Temperato as Chief Executive Officer
NEW YORK, March 18, 2019 -- (Healthcare Sales & Marketing Network) -- RDD Pharma, Inc., a specialty pharmaceutical company focused on innovative therapies for anorectal diseases and gastrointestinal disorders, today announced the appointment of industry v... Biopharmaceuticals, Gastroenterology, Personnel RDD Pharma, anal fissure, fecal incontinence, colitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 18, 2019 Category: Pharmaceuticals Source Type: news

Study suggests personality tests may improve care for prostate cancer patients
(European Association of Urology) Scientists have found that men with high neuroticism -- between a quarter and a fifth of men in developed countries -- are significantly more likely to suffer from adverse events such as erectile dysfunction and incontinence, which may put their recovery from prostate cancer surgery at risk. The researchers say that this means cancer teams may need to consider testing for personality types to try to ensure that patients being treated for prostate cancer receive the best care. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - March 15, 2019 Category: International Medicine & Public Health Source Type: news

Yoga for Incontinence? Evidence Is Lacking
Yoga exercises are often recommended to help control urinary incontinence in women, but there is no solid scientific evidence that they work. (Source: NYT Health)
Source: NYT Health - March 14, 2019 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Yoga Incontinence Women and Girls Age, Chronological Source Type: news

A Push for Push Dose Epinephrine
You transport a 79-year-old woman to the hospital for fever and urinary incontinence. Her family mentions a history of frequent urinary tract infections. Her initial vital signs are a heart rate of 115 bpm, an oxygen saturation of 97% on room air, and a blood pressure of 105/75 mmHg. You establish a peripheral IV line and begin a bolus of normal saline. About 15 minutes away from the hospital, you note the patient becomes increasingly drowsy. Her heart rate has increased to 125 bpm and her blood pressure is now 85/47 mmHg. What are your next steps? Prehospital Shock Starting in 2018, push dose epinephrine replaced dopamine...
Source: JEMS Patient Care - March 14, 2019 Category: Emergency Medicine Authors: Sammy Hodroge, MD Tags: Training Cardiac & Resuscitation Top Story Exclusive Articles Patient Care Source Type: news

As doctors and midwives finally act, a searing exposé of childbirth's shameful secret
Ten per cent of mothers who give birth through the birth canal will develop anal incontinence, according to the charity Masic Foundation claim. Katie Crowhurst, from London, is one of them. (Source: the Mail online | Health)
Source: the Mail online | Health - March 12, 2019 Category: Consumer Health News Source Type: news

BD ’ s Bard pulls all pelvic mesh products from EU market
Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard is removing its women’s pelvic organ prolapse and stress urinary incontinence mesh devices from the European Market, according to a recently posted field corrective action from the company. The Murray Hill, N.J.-based company said that it is “initiating a cease in production and distribution of these devices and a removal of these products from hospitals and distribution centers with immediate effect,” according to the notice. The removal of the devices was not a result of safety concerns, Bard clarified, adding that patients with such d...
Source: Mass Device - March 7, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Women's Health bectondickinson crbard Source Type: news

Axonics Modulation Technologies slides on misses Q4, 2018 earnings
Axonics Modulation Technologies (NSDQ:AXNX) took a hit after it posted fourth-quarter and 2018 losses that exceeded the consensus forecast on Wall Street. The company is developing a sacral nerve stimulation device to treat incontinence. Irvine, Calif.-based Axonics said yesterday that its losses grew 95.6% to -$9.6 million, or -50¢ per share, on sales of $494,000 for the three months ended Dec. 31, 2018, compared with the same period in 2017. Analysts on The Street were expecting losses of -32¢ on sales of $220,000. Full-year losses also grew, rising 86.0% to -$32.5 million, or -$4.64 per share, on sales growth ...
Source: Mass Device - March 6, 2019 Category: Medical Devices Authors: Brad Perriello Tags: MassDevice Earnings Roundup Neuromodulation/Neurostimulation Wall Street Beat Axonics Modulation Technologies Source Type: news

Study finds a lack of adequate hydration among the elderly
In this study, African-American participants had a salivary osmolality significantly lower than Caucasian participants, which would indicate less severe hydration problems, not more. Further research on hydration among African-Americans will be necessary to better understand these results.Other study colleagues include Michelle Devost, with the Los Angeles LGBT Center, and Karabi Nandy, with the University of North Texas Health Science Center in Fort Worth, both formerly at UCLA. (Source: UCLA Newsroom: Health Sciences)
Source: UCLA Newsroom: Health Sciences - March 6, 2019 Category: Universities & Medical Training Source Type: news

These 2 medical devices have sparked controversy
Sandra Maddock, president, IMARC Research The history of clinical research is filled with unfortunate examples of drug and device trials that involved serious ethical violations, injured patients or even resulted in death. It’s a sobering reminder of the many risks medical devices can pose to patients and the importance of compliance in clinical trials. Although many of these events occurred decades ago, medical devices still have the potential to cause harm. These issues are documented in the FDA’s annual list of medical device recalls and (in some rare cases) even make headlines. Here are two exampl...
Source: Mass Device - March 5, 2019 Category: Medical Devices Authors: Danielle Kirsh Tags: Blog IMARC Source Type: news

Women's Wellness: Bladder control problems
If you're one of the many women who experience bladder control problems, don't let embarrassment keep you from getting the help you need. Leaking urine, having to urinate frequently and experiencing other symptoms of urinary incontinence aren't trivial consequences of childbirth or a natural part of aging. Not all health care providers routinely ask about [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 28, 2019 Category: Databases & Libraries Source Type: news

Axonics Modulation touts results of sacral neuromodulation study
Axonics Modulation Technologies (NSDQ:AXNX) announced positive top-line results from a pivotal study of its novel implantable sacral neuromodulation (SNM) devices for the treatment of urinary and bowel dysfunction. The clinical study demonstrated that patients implanted with the Axonics r-SNM system experienced clinically meaningful and statistically significant improvements in urinary urgency incontinence (UUI) symptoms and quality of life, according to the Irvine, Calif.-based company. The study also met all secondary endpoints, and no serious device-related adverse events were reported. Get the full story on our si...
Source: Mass Device - February 21, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: Bioelectronic Medicine Clinical Trials Food & Drug Administration (FDA) Neuromodulation/Neurostimulation News Well Urology Axonics Modulation Technologies Source Type: news

Boston Scientific Launches Sling for Male Stress Urinary Incontinence
Boston Scientific recently launched its AdVance XP Male Sling System in the United States for male stress urinary incontinence (SUI). The company said the device has been redesigned for ease of placement and improved stability and is available in longer sling lengths to accommodate larger patient anatomy. The Marlborough, MA-based device maker said it worked with urologists to identify their needs during the product development process. Roughly 500,000 men worldwide suffer from SUI, Boston Scientific said, and about 8,000 to 9,0...
Source: MDDI - February 13, 2019 Category: Medical Devices Authors: MDDI Staff Tags: Business Source Type: news

Boston Scientific launches AdVance XP male stress urinary incontinence sling
Boston Scientific (NYSE:BSX) said late last week that it launched its AdVance XP male sling system intended to treat male stress urinary incontinence. The newly launched next-gen device includes a redesign intended to improve ease of placement and stability, and is available in longer sling lengths, the Marlborough, Mass.-based company said. “I believe the Advance XP Male Sling will allow my patients to get back to their normal, daily activities sooner. The modifications may help reduce post-operative sling slippage and may reduce the restrictions I previously pl...
Source: Mass Device - February 12, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Urology Boston Scientific Source Type: news

Women suffering from stress urinary incontinence can benefit from electroacupuncture
(Natural News) A study suggests that electroacupuncture can be used as a treatment for relieving stress urinary incontinence in women. In the study, which was published in Deutsche Zeitschrift für Akupunktur, researchers looked at the effect of electroacupuncture on stress urinary incontinence in women. Stress urinary incontinence is a bladder condition in which urine leaks... (Source: NaturalNews.com)
Source: NaturalNews.com - February 2, 2019 Category: Consumer Health News Source Type: news

UPDATE: Philly jury hits J & J ’ s Ethicon with $41m judgment in pelvic mesh case
Updated to include a response from Ethicon. Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon has been hit with a $41 million verdict in a pelvic mesh product liability suit in Philadelphia, according to a report from the Mesh News Desk. A jury in Philadelphia found that Ethicon’s Gynemesh, Prolift and TVT-O meshes were defective, and that the company was negligent in manufacturing the devices, according to the report. The plaintiff, Suzanne Emmett, was implanted with a Prolift pelvic mesh to treat pelvic organ prolapse, a TVT-O mesh as a treatment for incontinence and a Gynemesh implant, according to the...
Source: Mass Device - January 31, 2019 Category: Medical Devices Authors: Fink Densford Tags: Featured Legal News Women's Health Ethicon johnsonandjohnson Source Type: news

National study compares options for treating fecal incontinence
(Medical College of Georgia at Augusta University) Fecal incontinence, or accidental stool leakage, affects some 8 to 10 percent of the 325 million people in the United States. In up to half of patients, there is both fecal and urinary incontinence. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 29, 2019 Category: International Medicine & Public Health Source Type: news

Triple W Receives IHS Markit Innovation Award for DFree at International CES 2019
First Health Wearable Device for Urinary Incontinence Presented Honor at ShowStoppers CES Press Event San Diego (PRWeb) January 24, 2019 -- Triple W, an innovator of connected health devices, today announced it won the IHS Markit Innovation Award in the“Fitness, Wearables and Health Devices” category for DFree®, the first health wearable device for urinary incontinence. The award was presented at the ShowStoppers Consumer Electronics Show (CES)...This story is related to the following:Health Care Products (Source: Industrial Newsroom - Health...
Source: Industrial Newsroom - Health, Medical and Dental Supplies - January 28, 2019 Category: Medical Devices Source Type: news

An Evolutionary Concept Analysis of Urinary Incontinence An Evolutionary Concept Analysis of Urinary Incontinence
In this article, the development and utilization of a urinary incontinence concept analysis is described.Urologic Nursing (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 25, 2019 Category: Consumer Health News Tags: Urology Journal Article Source Type: news

Uromedica seeking $4 million to fund U.S. trials of device for women
Uromedica Inc. already markets an incontinence-treating device for men in the United States, but the market for women is potentially much bigger. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - January 18, 2019 Category: Biotechnology Authors: Alex Wittenberg Source Type: news

Neuromodulation: Using the brain ’ s internal language to relieve pain
When a patient walks into Dr. Jason Yong’s clinic at Brigham & Women‘s Faulkner Hospital complaining of pain, his work has just begun. “Pain is a common symptom and it’s totally generic,” Yong explained to MassDevice. “The other thing that makes it challenging is that it’s so subjective.” After Yong exhausts the pharmaceutical possibilities for managing his patient’s pain, he turns to technological options such as implantable neuromodulation systems. Neuromod devices use electrodes to deliver stimulation directly to a patient’s brain, spinal cord or peripheral...
Source: Mass Device - January 15, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Featured Neurological Pain Management Wall Street Beat Abbott Brigham & Women's Hospital Source Type: news

Doctors Question State Lawsuits Over Pelvic Mesh Products
THURSDAY, Jan. 10, 2019 -- State lawsuits over pelvic mesh products could scare women away from the products or even get them removed from the market, a group of doctors say. The products, used to treat pelvic floor disorders and incontinence, are... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 10, 2019 Category: Pharmaceuticals Source Type: news

Children who suffer from urinary incontinence may benefit from chamomile
(Natural News) Children who suffer from enuresis, also known as urinary incontinence, may benefit from chamomile (Matricaria recutita L.). A study published in the Journal of Evidence-Based Complementary & Alternative Medicine found that chamomile oil can help reduce the frequency of both nocturnal and daytime enuresis. Enuresis is the medical term for bedwetting. It is... (Source: NaturalNews.com)
Source: NaturalNews.com - January 9, 2019 Category: Consumer Health News Source Type: news

In Her words: 5 Reproductive Health Issues We Should Be Talking About
We asked readers which health topics they felt needed to be discussed openly, and got answers from an obstetrician-gynecologist. (Source: NYT Health)
Source: NYT Health - January 8, 2019 Category: Consumer Health News Authors: MAYA SALAM Tags: Women and Girls Premenstrual Syndrome (PMS) Menopause Incontinence Menstruation Vagina Uterus Pregnancy and Childbirth Gunter, Jennifer (1966- ) Source Type: news

Atlantic Therapeutics raises $32m Series B for garment-based UI stimulator
Atlantic Therapeutics said yesterday that it raised a Series B round worth $32 million for the garment-based device it makes to treat stress urinary incontinence. Innovo, an externally worn electrical muscle stimulation device, has CE Mark approval in the European Union and recently won de novo clearance from the FDA, Galway, Ireland-based Atlantic Therapeutics said. Clinical study results released last August showed that 87.2% of the Innovo group and 86.8% of the control group were in the dry or mild SUI categories at 12 weeks, representing an improvement of 32.7% for Innovo and 26.1% for the control group....
Source: Mass Device - January 8, 2019 Category: Medical Devices Authors: Brad Perriello Tags: Featured Funding Roundup Neuromodulation/Neurostimulation Urology Wall Street Beat Women's Health atlantictherapeutics Source Type: news

Man sues after false cancer diagnosis led him to have his prostate REMOVED
Rickie Lee Huitt, 67, has filed a lawsuit against the Iowa Clinic and Dr Joy Trueblood saying the urinary incontinence and erectile dysfunction side effects strained his relationship with his wife. (Source: the Mail online | Health)
Source: the Mail online | Health - January 7, 2019 Category: Consumer Health News Source Type: news

Hope for 14million Britons with urinary incontinence
Scientists from Northwestern University found switching on a tiny LED light in the bladder can block the nerve cells that cause people to urinate too often. (Source: the Mail online | Health)
Source: the Mail online | Health - January 2, 2019 Category: Consumer Health News Source Type: news

Urinary incontinences are related with fall and fragility fractures in elderly population: nationwide cohort study - Kim HJ, Kim JW, Jang SN, Kim KD, Yoo JI, Ha YC.
BACKGROUND: This prospective cohort study used nationwide claims data to investigate the incidence of fall and fragility fractures in association with urinary incontinence (UI) in the elderly, and to compare mortality after fragility fractures in elderly p... (Source: SafetyLit)
Source: SafetyLit - December 26, 2018 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Risk of 4 Pelvic Floor Disorders Associated With Delivery Mode (CME/CE)
(MedPage Today) -- Lower risk of stress urinary incontinence, overactive bladder, and pelvic organ prolapse with cesarean delivery than with surgical and non-surgical vaginal births (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - December 23, 2018 Category: OBGYN Source Type: news

Risk of Pelvic Floor Disorders Varied by Child Delivery Mode
(MedPage Today) -- Less likelihood of stress urinary incontinence with C-section, researchers say (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - December 19, 2018 Category: OBGYN Source Type: news

FDA approves Medtronic ’s multi-implant smart programmer
Comprised of a Samsung touch screen device and an app-based platfrom, the InterStim smart programmer helps patients and physicians more easily monitor incontinence implants.   (Source: mobihealthnews)
Source: mobihealthnews - December 18, 2018 Category: Information Technology Source Type: news

Pelvic Floor Disorder Risk Highest With Assisted Vaginal Delivery Pelvic Floor Disorder Risk Highest With Assisted Vaginal Delivery
The study, which followed women for two decades after childbirth, shows the lowest risk for pelvic floor disorders, such as urinary and anal incontinence, with C-section. Genital hiatus size also played a role.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 18, 2018 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Incontinence Drug May Help Ease Severe Hot Flashes
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - December 18, 2018 Category: General Medicine Source Type: news

Incontinence Drug May Help Ease Severe Hot Flashes
Oxybutynin, a drug widely used to treat urinary incontinence caused by an overactive bladder, helps treat hot flashes in breast cancer survivors and women who did not have breast cancer but who were bothered by frequent or severe menopausal symptoms, new research shows. (Source: WebMD Health)
Source: WebMD Health - December 17, 2018 Category: Consumer Health News Source Type: news

FDA Approves Smart Programmer for Medtronic Neuromodulation System
FDA approved a new smart programmer for Medtronic's InterStim system, which provides sacral neuromodulation therapy for the treatment of overactive bladder (OAB), chronic fecal incontinence (FI), and non-obstructive urinary retention. The new programmer streamlines multiple devices into a single, intuitive, touchscreen Samsung mobile device and enables clinicians to personalize each patient's care and allows patients to manage their therapy simply and discreetly, Medtronic said. According to the company, more than 37 million adults in the United States (almost one in six) suffer from OAB and nearly 20 million Americans (ab...
Source: MDDI - December 17, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Medtronic wins FDA nod for InterStim sacral neuromod programmer
Medtronic (NYSE:MDT) said today that the FDA approved its InterStim smart programmer, designed to work with the company’s InterStim sacral neurmodulation system intended for tor treating overactive bladder, chronic fecal incontinence and non-obstructive urinary retention. The newly cleared smart programmer is run on a Samsung Electronics (LON:BC94) mobile device and allows clinicians to personalize patient care and manage therapy from a single access point, the Fridley, Minn.-based medical giant said. “The incorporation of consumer technology in medical device solutions, such as the InterStim sys...
Source: Mass Device - December 17, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Neuromodulation/Neurostimulation Regulatory/Compliance Medtronic samsung Source Type: news

Certain Sites of Brain Lesions in MS Tied to Bowel Incontinence
FRIDAY, Dec. 14, 2018 -- Specific locations of cerebral multiple sclerosis lesions appear to be associated with bowel incontinence, according to a study published online Dec. 11 in the Journal of Neuroimaging. Kilian Frohlich, M.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 14, 2018 Category: Pharmaceuticals Source Type: news

FDA advisory panel to mull transvaginal mesh
The FDA plans to hold an advisory committee meeting in February 2019 to discuss the safety and efficacy of surgical transvaginal mesh as a treatment for pelvic organ prolapse. According to a document from the U.S. regulatory watchdog, the committee will be tasked with assessing the benefits and risks of placing mesh transvaginally in the anterior vaginal compartment, as well as clarifying the appropriate patient group and physician training needed for those products. The meeting will be open to the public, the FDA said, and the agency is requesting comments. Earlier this year, reports surfaced that Johnson & Johnson&nb...
Source: Mass Device - December 11, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Featured Women's Health FDA johnsonandjohnson Source Type: news

Could this vibrating chair really stop embarrassing leaks (and help your love life)?  
Like many women, Fiona Harris, 45, from Lincoln, suffered devastating incontinence. But a brand new treatment has transformed her life - and it only took three hours. (Source: the Mail online | Health)
Source: the Mail online | Health - December 10, 2018 Category: Consumer Health News Source Type: news

' It's Going to Be a Useful Agent': Oxybutynin for Hot Flashes'It's Going to Be a Useful Agent': Oxybutynin for Hot Flashes
A urinary incontinence drug is surprisingly effective in the treatment of hot flashes for both women with a history of breast cancer and those with menopausal symptoms but who do not have cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 10, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Viveve prices $20m offering
Viveve (NSDQ:VIVE) last week priced a follow-on offering worth $20 million. Englewood, Colo.-based Viveve’s eponymous device uses cryogen-cooled monopolar radiofrequency tech designed to treat gynecological conditions. The company said Dec. 6 that it floated 13.3 million shares at $1.50 apiece, for gross proceeds of $20.0 million. The offering includes a 30-day underwriters option on another 2.0 million shares that would reap $3.0 million if fully exercised. The offering is slated to close Dec. 11. Viveve said it plans to use the proceeds to continue commercializing its device, winning further regulatory clearan...
Source: Mass Device - December 10, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Featured Funding Roundup Wall Street Beat Women's Health Viveve Source Type: news

Drug May Cut Hot Flashes After Breast Cancer
A familiar drug for urinary incontinence has been found to reduce hot flashes in women after breast cancer. (Source: WebMD Health)
Source: WebMD Health - December 7, 2018 Category: Consumer Health News Source Type: news

Incontinence Drug May Cut Hot Flashes in Breast Cancer Survivors
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 7, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pharmacy, News, Source Type: news

Incontinence Drug, Oxybutynin (Ditropan XL) May Cut Hot Flashes in Breast Cancer Survivors
FRIDAY, Dec. 7, 2018 -- Hot flashes, a common curse in menopause, can be especially bothersome after breast cancer. But a new study suggests an existing medication may help. The drug is oxybutynin (Ditropan XL), long used to treat urinary... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 7, 2018 Category: General Medicine Source Type: news

Incontinence Drug Oxybutynin May Cut Hot Flashes in Breast Cancer Survivors
FRIDAY, Dec. 7, 2018 -- Hot flashes, a common curse in menopause, can be especially bothersome after breast cancer. But a new study suggests an existing medication may help. The drug is oxybutynin (Ditropan XL), long used to treat urinary... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 7, 2018 Category: General Medicine Source Type: news

Incontinence Drug May Cut Hot Flashes in Breast Cancer Survivors
FRIDAY, Dec. 7, 2018 -- Hot flashes, a common curse in menopause, can be especially bothersome after breast cancer. But a new study suggests an existing medication may help. The drug is oxybutynin (Ditropan XL), long used to treat urinary... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 7, 2018 Category: General Medicine Source Type: news